Skip to Content

Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) Drug Interactions

A total of 1312 drugs are known to interact with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).

  • 701 major drug interactions
  • 588 moderate drug interactions
  • 23 minor drug interactions

Show all medications in the database that may interact with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).

Check for interactions with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Type in a drug name and select a drug from the list.

Common medications checked in combination with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) alcohol/food interactions

There are 3 alcohol/food interactions with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) disease interactions

There are 32 disease interactions with Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:

More about Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Related treatment guides

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide